IMP3-saRNA Vaccine in Advanced NSCLC

Clinical trial NCT07561723 · RECRUITING

Trial details

NCT number: NCT07561723
Sponsor: West China Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2026-04-30
Primary completion: 2028-04-30
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.